Literature DB >> 3611300

Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin.

B J Averbook, R S Yamamoto, T R Ulich, E W Jeffes, I Masunaka, G A Granger.   

Abstract

These studies report findings that demonstrate that human alpha lymphotoxin (LT) induces local, visible, and microscopic inflammatory reactions in normal skin. Skin sites in rabbits, when inoculated with a single injection of native or recombinant human alpha lymphotoxin, demonstrated erythema, swelling, and warmth within 5 hr. Erythema peaked between 24 and 48 hr had resolved by 72 hr. Histologic studies of skin sites injected with native LT revealed polymorphonuclear neutrophil (PMN) infiltration and edema beginning as early as 3 hr posttreatment. Individual skin sites that received three daily injections of native LT exhibited persistent erythema and swelling. Palpable induration was evident 24 hr after the second injection in the series. Histologic examination revealed the presence of many PMNs with associated focal dermal destruction, in the form of microabscesses, and scattered mononuclear cells. In contrast, control materials and recombinant human tumor necrosis factor (TNF-alpha) did not induce visible skin reactions in the rabbit. Several additional controls excluded endotoxin as being the agent responsible for the inflammatory skin reactions observed. The ability of LT to induce inflammation may have a role in its antitumor activity and it may be an important endogenous mediator in other immunologic reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611300     DOI: 10.1007/bf00915556

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  A FACTOR CAPABLE OF INCREASING VASCULAR PERMEABILITY PRESENT IN LYMPH NODE CELLS. A POSSIBLE MEDIATOR OF THE DELAYED REACTION.

Authors:  D A WILLOUGHBY; B BOUGHTON; H O SCHILD
Journal:  Immunology       Date:  1963-09       Impact factor: 7.397

2.  Lymph node permeability factor in the dinitrochlorobenzene skin hypersensitivity reaction in guinea-pigs.

Authors:  D A Willoughby; M N Walters; W G Spector
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

3.  Release of skin reactive factor by human lymphocytes. An in vitro correlate of cellular immunity.

Authors:  Z Spirer; A Rudich; E Assif; V Zakut; N Bogair
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

4.  Skin reactive factor and lymph node permeability factor.

Authors:  J C Houck; D Barrantes; H Irausquin
Journal:  Agents Actions       Date:  1973-12

5.  Human lymphotoxins: purification to electrophoretic homogeneity of the alpha H receptor-bearing class.

Authors:  J Klostergaard; G A Granger
Journal:  Mol Immunol       Date:  1981-05       Impact factor: 4.407

6.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.

Authors:  B B Aggarwal; T E Eessalu; P E Hass
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

8.  Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro.

Authors:  R S Yamamoto; D L Johnson; I K Masunaka; G A Granger
Journal:  J Biol Response Mod       Date:  1984

9.  The biochemistry of lymphocyte-derived mediators of immunological inflammation.

Authors:  J C Houck; K B Hellman; C M Chang
Journal:  Agents Actions       Date:  1978-01

10.  The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.

Authors:  R S Yamamoto; C F Ware; G A Granger
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

View more
  6 in total

1.  Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines.

Authors:  S S Sung; L K Jung; J A Walters; E W Jeffes; G A Granger; S M Fu
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

2.  Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

Authors:  H I Yamanaka; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.

Authors:  T Gatanaga; C D Hwang; W Kohr; F Cappuccini; J A Lucci; E W Jeffes; R Lentz; J Tomich; R S Yamamoto; G A Granger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells.

Authors:  A Sica; K Matsushima; J Van Damme; J M Wang; N Polentarutti; E Dejana; F Colotta; A Mantovani
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues.

Authors:  G E Rice; J M Munro; C Corless; M P Bevilacqua
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

6.  A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon.

Authors:  M B Welborn; K Van Zee; P D Edwards; J H Pruitt; A Kaibara; J N Vauthey; M Rogy; W L Castleman; S F Lowry; J S Kenney; D Stüber; U Ettlin; B Wipf; H Loetscher; E M Copeland; W Lesslauer; L L Moldawer
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.